Mellman I S, Youngdahl-Turner P, Willard H F, Rosenberg L E
Proc Natl Acad Sci U S A. 1977 Mar;74(3):916-20. doi: 10.1073/pnas.74.3.916.
We identified previously an intracellular cobalamin (Cbl) binding protein(s) in cultured human fibroblasts, distinct from known Cbl "R" binders and absent from mutant cells deficient in the synthesis of the two Cbl coenzymes. In order to further characterize this binding activity, we have investigated its homologue in rat liver. After being transported to the liver by the serum protein transcobalamin II, [57Co]Cbl was bound by at least two distinct proteins, one cytosolic, the other mitochondrial. Labeled Cbl bound to cytosolic protein faster than or prior to the mitochondrial protein. With time there was a decline in radioactivity associated with the cytosolic binder and a coordinate increase in that associated with the mitochondrial binder. Although both proteins cochromatographed on Sephadex G-150 and had apparent molecular weights of 120,000, they were separated into two discrete components by polyacrylamide gel electrophoresis and by DEAE-cellulose chromatography. The cytosolic binder cochromatographed with N5-methyltetrahydrofolate:homocysteine methyltransferase activity (5-methyltetrahydropteroyl-L-glutamate:L-homocysteine S-methyltransferase, EC 2.1.1.13); the mitochondrial one with methylmalonyl CoA mutase activity (methylmalonyl-CoA CoA-carbonylmutase, EC 5.4.99.2). These proteins were distinguished further by the chemical forms of [57Co]Cbl found with them, hydroxocobalamin and methylcobalamin with the cytosolic protein and adenosylcobalamin with the mitochondrial one. These results suggest that intracellular Cbl binding activity in rat liver can be accounted for by attachment of Cbl to the two known Cbl-dependent apoenzymes, methylmalonyl CoA mutase and methyltetrahydrofolate methyltransferase. The mechanism and significance of the observered binding protein deficiency in mutant human fibroblasts must, therefore, be re-evaluated.
我们先前在培养的人成纤维细胞中鉴定出一种细胞内钴胺素(Cbl)结合蛋白,它不同于已知的Cbl“R”结合蛋白,且在缺乏两种Cbl辅酶合成的突变细胞中不存在。为了进一步表征这种结合活性,我们研究了其在大鼠肝脏中的同源物。[57Co]Cbl通过血清蛋白转钴胺素II转运到肝脏后,与至少两种不同的蛋白结合,一种是胞质蛋白,另一种是线粒体蛋白。标记的Cbl与胞质蛋白的结合比与线粒体蛋白的结合更快或更早。随着时间的推移,与胞质结合蛋白相关的放射性下降,而与线粒体结合蛋白相关的放射性相应增加。尽管这两种蛋白在Sephadex G - 150上共色谱,且表观分子量均为120,000,但通过聚丙烯酰胺凝胶电泳和DEAE - 纤维素色谱可将它们分离为两个离散的组分。胞质结合蛋白与N5 - 甲基四氢叶酸:同型半胱氨酸甲基转移酶活性(5 - 甲基四氢蝶酰 - L - 谷氨酸:L - 同型半胱氨酸S - 甲基转移酶,EC 2.1.1.13)共色谱;线粒体结合蛋白与甲基丙二酰辅酶A变位酶活性(甲基丙二酰 - 辅酶A辅酶A - 羰基变位酶,EC 5.4.99.2)共色谱。通过与它们结合的[57Co]Cbl的化学形式进一步区分这些蛋白,与胞质蛋白结合的是羟钴胺素和甲基钴胺素,与线粒体蛋白结合的是腺苷钴胺素。这些结果表明,大鼠肝脏中的细胞内Cbl结合活性可通过Cbl与两种已知的Cbl依赖性脱辅基酶,即甲基丙二酰辅酶A变位酶和甲基四氢叶酸甲基转移酶的结合来解释。因此,必须重新评估在突变的人成纤维细胞中观察到的结合蛋白缺乏的机制和意义。